FDA approves new surgical treatment for enlarged prostates

A transurethral resection of the prostate is considered the gold-standard treatment for benign prostatic hyperplasia. But newer, less invasive procedures offer faster recovery times and fewer risks of complications. Earlier this year another new procedure won the FDA's approval.